Otitis media (OM), inflammation of the middle ear (ME), is a common cause of conductive hearing impairment. Despite the importance of the disease, the aetiology of chronic and recurrent forms of middle ear inflammatory disease remains poorly understood. Studies of the human population suggest that there is a significant genetic component predisposing to the development of chronic OM, although the underlying genes are largely unknown. Using N-ethyl-N-nitrosourea mutagenesis we identified a recessive mouse mutant, edison, that spontaneously develops a conductive hearing loss due to chronic OM. The causal mutation was identified as a missense change, L972P, in the Nischarin (NISCH) gene. edison mice develop a serous or granulocytic effusion, increasingly macrophage and neutrophil rich with age, along with a thickened, inflamed mucoperiosteum. We also identified a second hypomorphic allele, V33A, with only modest increases in auditory thresholds and reduced incidence of OM. NISCH interacts with several proteins, including ITGA5 that is thought to have a role in modulating VEGF-induced angiogenesis and vascularization. We identified a significant genetic interaction between Nisch and Itga5; mice heterozygous for Itga5-null and homozygous for edison mutations display a significantly increased penetrance and severity of chronic OM. In order to understand the pathological mechanisms underlying the OM phenotype, we studied interacting partners to NISCH along with downstream signalling molecules in the middle ear epithelia of edison mouse. Our analysis implicates PAK1 and RAC1, and downstream signalling in LIMK1 and NF-κB pathways in the development of chronic OM.
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Introduction
Otitis media (OM) is characterised by inflammation of the middle ear (ME), often associated with a conductive hearing impairment, and is the commonest cause of hearing loss in children. It is perceived by many to be a transient affliction that in reality places a substantial social, medical and economic burden on healthcare systems globally [1] . Evidence from studies of the human population suggests that there is a significant genetic component predisposing to the development of recurrent and chronic forms of OM [2, 3] . Despite the importance of the disease, many of the genes involved in OM susceptibility have still yet to be identified. At present, the use of mouse models is the most promising method to identify candidate loci underlying susceptibility to OM. Mouse models have highlighted the role of Toll-like receptors (TLRs) in acute OM, in particular the protection against commensal and pathogenic bacteria, and that persistent NF-κB or TGF-β signalling could be two mechanisms leading to the overactive proinflammatory response seen in chronic OM [4, 5] .
The large-scale phenotype-driven mouse ENU (N-ethyl-N-nitrosourea) mutagenesis program at MRC Harwell [6, 7] has previously identified two novel mouse mutants, Jeff and Junbo, that develop a conductive hearing loss characterised by ME fluid and mucosal inflammation [8, 9] . The Jeff mouse has a mutation in the Fbxo11 gene [10] and the Junbo mouse has a mutation in Evi1 [9] . Studies have revealed that these genes, are involved in signalling of the TGF-β superfamily, via SMAD proteins [11, 12] ; negatively regulate NF-κB-dependent inflammation [13] ; and highlight the role of HIF-VEGF pathways in the underlying genetic and pathophysiological mechanisms that predispose to chronic OM [14] .
OM mouse models with single gene mutations have identified a number of genes as candidate susceptibility genes for human OM, including Tlr2, Tlr4, p73, E2f4, Plg, Tgif1, Evi1 and Fbxo11 [4] . These genes identified from mouse models of OM are beginning to be studied in the human population; with significant associations between OM and polymorphisms in FBXO11 [15, 16] , TLR2 [17] and TLR4 [17] [18] [19] .
We have identified and characterised a novel OM mouse mutant, edison, from the ENU mutagenesis program at MRC Harwell. Homozygous edison mice spontaneously develop a conductive hearing loss associated with chronic inflammation of the ME, sharing many features with chronic OM in humans. The underlying mutation of this phenotype has been identified as a mutation in the Nisch gene. We have explored the role of Nisch in chronic OM, relating the edison phenotype to the underlying mechanisms of Nisch function. We have utilised double mutants to assess genetic interactions and pathways involved, implicating PAK1 and RAC1, and downstream signalling events in LIMK1 and NF-κB signalling pathways in the development of chronic OM. Overall, the edison mouse highlights a new candidate gene for susceptibility to chronic OM and has provided further insight into the genetic pathways and pathogenic processes involved.
Results

Identification of the edison mutation
A phenotype-driven ENU mutagenesis screen [20] identified a new recessive mutant, edison (edsn), with hearing loss. Preliminary phenotyping using a click-box test (20 kHz, 90 dB sound pressure level (SPL) tone burst) of an age-matched cohort derived from the founder mouse indicated that 6-week-old (wk) mice demonstrated a reduced startle response. SNP-based linkage analysis and mapping identified an approximately 9 Mb interval on chromosome 14 delineated by marker rs30778552 and rs46823676 containing 119 genes ( Fig 1A) . Whole-genome sequencing identified 60 ENU-induced, de novo variants within the critical 9Mb interval and importantly only one missense variant was identified. This missense variant was a c.3079T>C substitution in Nischarin (Nisch) (open reading frame of NCBI RefSeq transcript NM_022656.2) that results in a Leu972Pro substitution (Fig 1B) . The change occurs in a highly conserved region that has been maintained through evolution (Fig 1C) . PROVEAN analysis predicts that this change is ''deleterious" and SIFT predicts that it is ''not tolerated". No other non-synonymous sequence changes were identified within the minimal interval. The Nisch locus encodes a protein of 1,593 amino acids, coded for by 22 exons. The protein consists of an N-terminal phox homology (PX) domain, six putative leucine-rich repeats (LRRs), a predicted coiled-coil (CC) domain, an alanine/ proline-rich region and a long C-terminal region (Fig 1D) .
DNA and sperm archives derived from ENU mutagenesis programmes [21] were utilised to identify an additional allele at the Nisch locus. We screened ten exons of Nisch employing high resolution melting analysis of~10,000 mutant mice and identified a c.98T>C substitution resulting in a Val33Ala substitution within a conserved region of the NISCH PX domain. We rederived this second allele, Nisch
V33A
, and examined the phenotypes.
Anatomical and histological analysis of edison mutant
Reduced numbers of edison progeny. Heterozygous animals (Nisch edsn/+
) were intercrossed to generate wild-type control, heterozygous and homozygous (Nisch edsn/edsn ) populations for the study and the progeny were genotyped. The homozygous mutants were viable, but the frequency of homozygous mutant offspring at weaning age was 15 , p < 0.001). Mild craniofacial defects in edison mice. We found that all Nisch edsn/edsn mice demonstrated a shortened snout compared with wild-type mice, indicating a mild craniofacial abnormality (S1 Fig). To investigate the craniofacial phenotype of mice, we took dorsoventral X-ray images of the skulls and computed cranial measurements (S1C Fig). To determine whether any of the cranial bones showed disproportionate growth, allometric comparisons against skull length were used to normalise the data for differences in body size (S1C and S1D Fig) . animals when compared with wild-type mice, suggesting a conductive hearing loss.
Visual inspection of the tympanic membrane is a simple method for diagnosing OM. The cloudy appearance of an eardrum is a semi-quantitative measure of bulla fluid accumulation and the incidence of OM was assessed in edison mice (Fig 2D) ultra-structural analysis of the inner ear with scanning electron microscopy showed no evidence of hair cell damage or hair cell loss, with Nisch edsn/edsn mice displaying normal cell and bundle morphology throughout the cochlear turn (basal, mid and apical). Histological analysis of middle ear demonstrates chronic otitis media. Histological examination was performed to investigate the pathological changes in the ME of edison mice (Fig 3) . Wild-type and Nisch edsn/+ mice at 20 weeks displayed clear ME cavities, lined with a thin mucoperiosteum (Fig 3A and 3B) . Nisch edsn/edsn mice develop chronic otitis media with ME cavities filled with a cellular exudate and lined with a thickened mucoperiosteum (Fig 3C  and 3D ). The mucosal inflammation was diffuse and of moderate severity. Papillary to polypoid exophytic growths were observed projecting into the ME cavity (Fig 3E) . The polypoid projections were most likely due to fibroblast stimulation as a consequence of chronic inflammation. There were small accumulations of inflammatory cells and dilated lymphatic and blood vessels in the mucoperiosteum (Fig 3E) . In middle ears with the most severe phenotype, there were instances showing inflammation of the tympanic membrane (Fig 3F) . There were differing types of ME effusion: a thin watery effusion, a dense granulocyte-rich effusion, or a combination of both (Fig 3G-3I ears (71%, n = 14 ears), and only three mice had a thin watery effusion (21%, n = 14 ears). At 4 wk, there were five Nisch edsn/edsn ears that contained fluid in the ME cavity with a thickened epithelial lining (50%, n = 10 ears). Two ears had a thin watery effusion, and three ears displayed a cellular effusion with the presence of polymorphonuclear cells (PMNs) that are the first responding inflammatory cells that migrate towards the site of inflammation. In 6 wk Nisch edsn/edsn animals, four ears showed inflammation in the ME cavity with a thickened epithelial lining (33%, n = 12 ears), with three of these ears also containing a cellular effusion. By 8 wk, the inflammation in Nisch edsn/edsn animals had progressed to a chronic inflammation with effusion, as evidenced by a thick cellular fluid in the bulla cavity along with a greatly thickened ME mucosa (67%, n = 12 ears). There was variability in the type of effusion found, where two ears exhibited a serous effusion and in six ears the ME fluid was thick with the presence of macrophages and PMNs. Nisch edsn/edsn mice studied at 20 wk displayed a chronic inflammation with effusion, similar to what was observed at 8 wk. Seventeen ears presented a chronic inflammation (77%, n = 22 ears), eleven of which contained fluid. Ten ears exhibited a thick effusion with the presence of macrophages and PMNs and in only one ear a serous exudate was observed. Cellular debris-like aggregates were present in the thick effusions and developing polyps were observed in the ME mucosa. age, we studied the mice at E16.5, E18.5 and P0 to search for any physiological defect that may contribute to lethality (Fig 4A-4D ). In some Nisch edsn/edsn mice we observed morphological lung defects including thickened interstitial mesenchyme and smaller airspaces than in wildtype littermates. At E16.5, 33% of Nisch edsn/edsn lungs appeared severely affected (n = 6). This was replicated at E18.5 and P0, whereby 30% (n = 10) and 29% (n = 7) of Nisch edsn/edsn lungs appeared severely affected respectively. At each time point, the width of airspaces in severely affected Nisch edsn/edsn mutants was significantly smaller than wild-type tissue (one-way ANOVA: p < 0.001), whereas no difference in the number of airspaces was observed. The reduced numbers of Nisch edsn/edsn progeny are likely a consequence of their lung defect.
Consistent with a number of other adult mouse mutants harbouring defects in embryonic lung generation [22] , histological evaluation of adult edison lungs revealed enlargement of the airspaces in Nisch edsn/edsn mice, characteristic of an emphysema-like phenotype (Fig 4E-4H ).
On average, the airspace width in surviving adult Nisch edsn/edsn lungs was significantly larger than wild-type tissue (Kruskall-Wallis: p < 0.001). Moreover, in Nisch edsn/edsn lungs quantification of the number of airspaces indicated a significant decrease compared to wild-type (KruskallWallis: p < 0.001). Interestingly, the severity of the emphysema-like lung phenotype observed in Nisch edsn/edsn replicates the severity of the OM phenotype in the ME (Fig 4I-4M (Fig 4N) . In contrast, abnormal accumulations of enlarged alveolar macrophages containing coarsely granular material were observed within the lungs of Nisch edsn/edsn mice (Fig 4O) .
Genetic interaction of Nisch and Itga5
NISCH binds to the cytoplasmic domain of ITGA5 [23] , and is thought to regulate its expression [24] . Cross-talk between VEGF and integrins has been shown to be a critical factor in the regulation of angiogenesis and vascularization [25] . μm; A, B, E, F, I, J, K scale bar = 100 μm. ns P > 0.05; * P < 0.05; ** P < 0.01; *** P < 0.001. Error bars indicate standard error of mean. Embryonic lung data in panels C and D were analysed by one-way ANOVAs and Holm-Sidak's multiple comparison procedures for post-hoc testing. Adult lung data (G, H, L, M) was not normally distributed and a Kruskall-Wallis test was performed followed by Dunn's multiple comparison tests for post-hoc analysis.
https://doi.org/10.1371/journal.pgen.1006969.g004 ; Nisch edsn/edsn n = 9. C, cochlea; ET, eustachian tube; E, exudate; MEC, middle ear cavity; MP, mucoperiosteum (arrowheads); TB, temporal bone; TM, tympanic membrane. E, G, I scale bar = 2 mm; F, H, J scale bar = 200 μm. ns P > 0.05; * P < 0.05; ** P < 0.01; *** P < 0.001. Error bars indicate standard error of mean. A Kruskall-Wallis test was performed followed by Dunn's multiple comparison tests for post-hoc analysis. ) exhibited a mild late-onset hearing loss, with onset at 12 wk (Fig 5A) . Visualisation of the tympanic membrane showed this mild hearing loss was associated with a late-onset in the prevalence of OM from 12 We proceeded to investigate the expression of interacting partners to NISCH, including ITGA5, as well as key downstream effectors in order to relate the underlying mutation to the edison phenotype. In addition to binding ITGA5, NISCH has also been shown to interact directly with PAK1 [23, 26] , and RAC1 [27] . As well as being a downstream effector of PAK1, LIMK1 [28] also interacts directly with NISCH. In addition PAK controls NF-κB activation [29] and RAC1 leads to activation of NF-κB [30, 31] . We thus performed IHC expression analysis of NISCH, ITGA5, phosphorylated-PAK1 (p-PAK1), phosphorylated-LIMK1/2 (p-LIMK1/2), RAC1 and NF-κB p65 on ME epithelia from wild-type, ; Nisch edsn/edsn mice (Fig 6A-6C) . Western analysis of ME epithelial cell lysates showed raised levels of ITGA5 in Nisch edsn/edsn mice but not 
wk, probed with (A) ITGA5, (B) PAK1, (C) p-LIMK1/2, (D) LIMK1, (E) RAC1, (F) NF-κB p65, (G) p-NFκB p65, (H) FAK, (I) p-FAK, (J) p-SRC and (K) p-SMAD2 antibodies.
The results presented are from four independent experiments for all the antibodies except for ITGA5, PAK1, LIMK1, p-NFκB p65 and FAK, where three independent experiments were used to present the data. ns P > 0.05; * P < 0.05; ** P < 0.01; *** P < 0.001. Error bars indicate standard error of mean. A Student's t-test was performed to analyse the data. (Fig 6F) . In agreement with IHC, we found significantly higher levels of NF-κB p65 by western blot in both mutants compared to wild-type (t-test: p = 0.039 and p = 0.041) ( Fig  7F) . We also examined levels of activated NF-κB p65 by western blot employing an antibody that recognises phosphorylated-NF-κB [Ser 276] p65 (p-NF-κB p65) and detected significantly higher levels of the activated protein in both mutants compared to wild-type (t-test: p = 0.030 and p = 0.035) (Fig 7G) . In addition, we investigated the expression of two pathways that are implicated in the development of chronic OM (see Introduction), or are regulated by NISCH interacting partners. First, we evaluated levels of focal adhesion kinase (FAK) and SRC. Cross-talk between integrins and VEGF is a critical factor in the regulation of angiogenesis, vascularisation and vascular permeability [25] . Integrins regulate VE-cadherin via the activation of SRC, and FAK catalytic activity is required when α5β1 integrin stimulates SRC activation through FAK phosphorylation. FAK inhibition prevents VEGF-stimulated vascular permeability underlining the importance of FAK activity in the regulation of adherens junctions [32] . Tyr 397 in human FAK becomes phosphorylated upon integrin engagement and creates a binding site for SRC. This results in release of the inactive conformation of SRC (Tyr 527) and leads to autophosphorylation of SRC on Tyr 416. Activated SRC further phosphorylates FAK on additional residues, one of which is Tyr 576. The activated FAK-SRC complex then initiates multiple downstream signalling pathways [33, 34] 
To study protein levels of FAK we used an antibody raised against the last 50 amino acids at the C-terminal of the human protein. There are nine known mouse isoforms of FAK (http:// www.uniprot.org/uniprot/P34152) produced by alternative promoter usage and alternative splicing and the antibody is potentially able to detect six of them. We detected three main bands in ME epithelial cell lysates at 124, 115 and 100kDa. The full-length canonical isoform is 124kDa. We detected significantly increased levels of the full length 124kDa FAK1 protein in Nisch edsn/edsn mutants compared to wild-type (t-test: p = 0.014). The chronic OM in Nisch edsn/edsn mice is exemplified by exudate within the ME cavity and a thickened mucoperiosteum and polypoid exophytic growths, sometimes associated with an inflamed tympanic membrane. Serous or granulocyte-rich effusions were observed, but as the mice aged a thick effusion was predominately observed rich in macrophages and PMNs. Examination of ME exudates for upregulation of both inflammatory genes and hypoxia genes found that both Il-1b and Tnfa were both upregulated, as were Hif1a and the HIF responsive gene Vegfa. This is similar to the findings reported for other mouse models of chronic OM, such as the Jeff [8] , Junbo [9] and Tgif1 [35] mutants. Both the middle ear and the lungs have substantial similarities in structure and function [36] and, intriguingly, we identified a lung defect in Nisch edsn/edsn mice. During embryonic development, we found a significant reduction in airspace width, while in the adults, we observed an emphysema-like phenotype with enlarged airspace width and a reduced number of airspaces. In utero, the network of airways is generated first followed by formation of the gas-exchanging units (alveoli) that develop from the distal ends of the small airways. As a consequence disruption to lung development often results in narrower airspaces in embryonic lungs but enlarged airspaces post-natally because of insufficient generation of alveoli. These lung abnormalities likely account for the deficit of Nisch edsn/edsn mice recovered from the various crosses that we report.
The discovery of the involvement of Nischarin in the development of inflammatory middle ear disease identifies a novel gene and associated pathways that are involved in OM. This led us to explore the intersection with known pathways of OM [11, 13, 14] and the downstream signalling mechanisms that lead to the OM phenotype. Nischarin is a highly conserved protein across mammalian species, consisting of an N-terminal phox homology (PX) domain, 6 putative leucine-rich repeats, a coiled-coil domain, an alanine/proline-rich region and a long C-terminal region. NISCH has a multitude of interacting partners, including ITGA5 [37] , PAK1 [26] , Rac1 [27, 38] , LIMK1 [28] , Rab14, PI3P [38] , and LKB1 [39] . Association of NISCH with these interacting partners underlines its broad impact on the regulation of cell motility, cell invasion, vesicle maturation, as well as its role as a tumour suppressor [28, 37, 38, 40] . Most notably, the binding of NISCH to ITGA5 [37] is thought to mediate the translocation of ITGA5 from the cell membrane to endosomes [24] thus regulating ITGA5 levels. As we discuss above, integrins have been shown to play a critical role in modulating VEGF-induced angiogenesis and vascularization [25] . These pathways thus intersect with the hypoxia-response pathways mediated by HIF-1a which have been demonstrated to be involved with the development of chronic OM in the Junbo and Jeff models [14] . Hypoxia leads to upregulation of VEGFA and downstream pathway genes resulting in VEGF-induced angiogenesis and vascular leak. VEGFR inhibitors moderated angiogenesis and lymphangiogenesis in the Junbo mouse. For these reasons we sought to explore the role of ITGA5 in the edison mutant, and also to characterise the responses of downstream pathways which may illuminate the mechanisms of OM development in edison.
We found a strong genetic interaction between edison and Itga5 mutants. Itga5 tm1Hyn/+ ; Nisch edsn/edsn double mutants compared to Nisch edsn/edsn mice showed significantly elevated ABR thresholds as well as a very significant raised frequency of bilateral OM in mice from 4 weeks onwards. In summary, the OM was more highly penetrant from an earlier age, and commensurately less progressive. Given the interactions of ITGA5 and NISCH, along with the interactions of NISCH with diverse molecules involved in LIMK1 and NF-κB signalling, we sought to interpret this genetic interaction in the context of known signalling pathways and interactions downstream of NISCH. Moreover, in developing a mechanistic model, we took into account the reports that interaction of ITGA5 with NISCH affects some of the downstream interactions of the NISCH molecule itself. RAC1 signalling regulates disparate cellular functions mediated through a variety of effector proteins [30, 31] . PAK1 is a key downstream effector of RAC1 [41, 42] , with binding of RAC1 leading to activation of PAK1 [43] . NISCH represses this pathway, and NISCH has been shown to block RAC1 induced cell migration through binding to PAK1; interaction with NISCH strongly inhibits the kinase activity of PAK1 [23] . RAC1 activation of PAK1 enhances the interaction between NISCH and PAK1, while notably expression of ITGA5 also increases the association between NISCH and PAK1 [23] . LIMK1 is a downstream effector of PAK1 [44] and has been shown to be involved in vascular permeability [45] . NISCH is also an interacting partner with LIMK1, regulating cell invasion through repression of the LIMK1-cofilin pathway [28] . NISCH also regulates PAK1-independent RAC1 signalling through direct interaction with RAC1 [27] . RAC1 stimulates the phosphorylation and degradation of IkB and up-regulates NF-κB [46, 47] . Overexpression of NISCH has been shown to suppress the ability of RAC1 to stimulate NF-κB activation [27] . The Junbo OM mutant carries a mutation in the Evi1 gene, and it is noteworthy that EVI1 is a negative-feedback regulator of NF-κB [13] . The mutation in Junbo leads to activation of NF-κB and inappropriate regulation of the inflammatory response [13] .
We have assessed the expression of the critical genes within these pathways in the ME epithelia of wild-type, Overall, our analysis indicates that the edison mutation leads to activation of PAK1 and PAK1-independent RAC1 pathways with increased levels of NF-κB and p-LIMK1/2 each of which may lead to inflammatory and vascular permeability effects. In addition, a combination of mutations in NISCH and ITGA5 can lead to an exacerbation of raised protein levels which may underlie the more severe phenotype seen in the double mutant, Itga5 (Fig 8) . We surmise that impairing function of NISCH leads to derepression of RAC1 pathways, while reducing levels of ITGA5 in combination with impaired NISCH leads to further derepression and activation of downstream pathways manifested in the more severe phenotype. However, we did not observe significantly raised levels of RAC1 in the single mutant. Nevertheless, we found raised levels of NF-κB that may reflect activation of PAK1 independent pathways. ITGA5 is known to be involved with the activation of SRC protein tyrosine kinase, as well as FAK, both of which are involved with mediating VEGF induced vascular leak [32] . ITGA5 can mediate its effects by phosphorylation of FAK and binding of activated FAK to SRC leading to conformational SRC activation [33] . Alternatively, for example in the context of neuroblastoma cell motility, FAK is required for integrin α5β1-mediated SRC phosphorylation [34] . We thus investigated FAK and SRC levels in the mutant mice, focusing on activated FAK and inactive SRC. We found total levels of the full length isoform of the FAK protein raised in Nisch edsn/edsn mice. However, in Itga5 tm1Hyn/+ ; Nisch edsn/edsn mice, full length FAK protein was not significantly different to wild-type. Importantly, we detected raised levels of activated FAK along with reduced levels of inactive SRC in Nisch edsn/edsn mice. These changes may contribute to angiogenesis and vascular permeability through upregulation of VEGF signalling pathways.
The genes mutated in previously characterised OM models (Junbo, Jeff and Tgif1), have been reported to regulate the TGF-β signalling pathway [11, 12, 35] . There is considerable cross-talk between TGF-β signalling and hypoxia pathways and mutations that perturb the TGF-β pathway might be expected to perturb hypoxia responses with downstream consequences on VEGFA and VEGF signalling, as is observed in the mutants studied [14] . We discuss above the raised levels of HIF-1a and VEGFA found in the edison mutant. We thus assessed TGF-β signalling (in edison), and found that p-SMAD2 levels are significantly raised in Itga5 . The lack of raised p-SMAD2 levels in the Nisch edsn/edsn mouse suggests that activation of TGF-β signalling is not a primary event underlying the development of chronic OM in the edison mouse. Rather, the upregulation of p-SMAD2 in the double mutant may reflect the very severe inflammatory state of the middle ear leading to activation of TGF-β pathways. In summary (see Fig 8) , we conclude that mutations in Nischarin impact upon PAK-dependent and PAK-independent RAC pathways with downstream signalling effects on LIMK1 and NF-κB. Moreover, the interplay between Nischarin and ITGA5 likely underlies impacts on FAK and SRC signalling which may lead to VEGF mediated vascular leak. The combined effects on LIMK1, NF-κB and FAK signalling can account for the observed inflammatory changes in the edison middle ear, which along with vascular leak and middle ear exudate, produce a chronic OM. Together, the pathways changes we describe provide a mechanism underlying the observed phenotypic changes in edison. Moreover, these studies further enhance our knowledge of the relevant genetic pathways that contribute to middle ear inflammatory disease, as well as a panel of new genes that are candidates for genetic susceptibility to chronic OM in the human population.
Materials and methods
Ethics statement
Mice were bred and maintained by Mary Lyon Centre, MRC Harwell and were housed in specific-pathogen free conditions. All animal experimentation was approved by the Animal 
Phenotype-driven ENU-mutagenesis screen
The founder mouse carrying the edison mutation was generated in a large-scale phenotypedriven ENU mutagenesis program at MRC Harwell [20] . Briefly, Male C57BL/6J mice were mutagenized and mated to C3H.Pde6b+ females (a C3H stock that does not carry the retinal degeneration allele Pde6b rd ). G 3 offspring were screened for a variety of abnormalities, including deafness and vestibular dysfunction. The edison founder was identified due to lack of a Preyer reflex when presented with a calibrated 20 kHz, 90 dB SPL tone burst via a clickbox test.
Mapping
The founder edison mouse was maintained by repeated outcrossing to C3H/HeH and intercrossing to produce homozygous mutant progeny, identified by the lack of a Preyer reflex. For linkage analysis genomic DNA from 13 affected mice were screened with 63 strain specific SNP markers spaced equidistantly across the genome using the Pyrosequencing SNP genotyping system (QIAGEN). Additional SNP markers were used within linked regions to further fine map the causal mutation. Markers and primer sequences are available on request from the authors.
Whole-genome sequencing
Genomic DNA from a single affected edison mouse was sent for next-generation sequencing (High-Throughput Genomics, WTCHG). Identification, analysis and dissemination of sequence variant information identified through whole-genome sequencing were achieved with the tools provided by the MRC Harwell Biocomputing custom sequence analysis pipeline. Sequence reads were mapped to the NCBI37/mm9 assembly of the reference mouse genome. Within the critical interval, the mean read depth was 8.17 and the read coverage was 99.64%. Sequence variants were identified and were subsequently categorised into those which occurred within exons and splice donor/acceptor sites, and were not known or strain-specific variants. This led to the identification of a T to C base substitution within exon 14 of Nisch, which is predicted to cause a Leu972Pro missense change in NISCH protein. This sequence variant was validated using Sanger sequencing (Source BioScience, UK). Affected and unaffected mice were genotyped using the LightScanner SNP genotyping system (Idaho Technology Inc., USA) to confirm the association of genotype to phenotype. In all cases the genotype correlated with the phenotype.
Gene-driven identification of an additional Nisch allele
DNA from the MRC Harwell ENU-DNA sperm archive (http://www.har.mrc.ac.uk/services/ archiving-distribution/enu-dna-archive) was screened with the LightScanner platform (Idaho Technology Inc., USA). Briefly, male C57BL/6J mice were treated with ENU and crossed to C3H/HeH females. F 1 progeny (C3H/HeH.C57BL/6J) were rederived and male F 1 animals had sperm and DNA samples taken for archiving. Ten exons of Nisch were screened in DNA from 10,000 F 1 ENU mutagenised animals and potential mutations confirmed with Sanger sequencing (Source BioScience, UK).
Genetic background
All edison mice used for phenotyping were congenic on a C3H/HeH background. They were backcrossed for at least ten generations. 
Skull morphology and radiography
Analysis of skulls from 20 wk mice was performed using a Faxitron Mx-20 DC-4 specimen Xray System. ImageJ software was used to measure the skull length, nasal bone length, frontal bone length, parietal bone length and skull width. Allometric comparisons were performed against skull length with at least 12 mice of each genotype.
Auditory brainstem response
Mice were anesthetized and hearing thresholds determined using ABR, as previously described [7] . The ABR threshold was measured for each ear. substitute and rehydrated via a graded ethanol. For morphological observations, sections were stained with haemotoxylin and eosin (H&E). The histological sections were used to investigate the middle ear inflammation of the mice. Evaluation of mean mucosal thickness was by blinded assessment of a standard 1000 μm length of ME mucosa (avoiding the cochlea and the region close to the Eustachian tube), the mucosal thickness was averaged from five measurements.
To study the lung morphology of edison mice, H&E stained sections from adult and perinatal lungs were viewed using a Zeiss Axiostar Plus bright-field microscope and analysed using cell B imaging software (Olympus). The data was analysed as previously described [49] .
Scanning electron microscopy
To study the ultra-structure of the organ of Corti we dissected the inner ears from five 20 wk Nisch +/+ and Nisch edsn/edsn mice and prepared the samples as previously described [50] . Inner ears were imaged using a JEOL 6010 LV scanning electron microscope under high vacuum conditions.
Blood and bulla fluid collection
Blood and bulla fluids were collected, as previously described [14] , for analysis using Real-time quantitative PCR.
antibodies were from the Vectastain Elite ABC kit and they were used according to the manufacturer's instructions. DAB+ chromogen system (DAKO K3468) was used to develop the specific signals. The slides were counterstained with haematoxylin. 
Western blot
Data analysis
All data are given as unadjusted mean +/-SEM (standard error of the mean) unless stated otherwise. Data were analysed to establish normal distribution. Where data was normally distributed an ANOVA or Student's t-test were conducted. If data was not normally distributed the non-parametric equivalents of these tests were used (Kruskal-Wallis One Way Analysis of Variance on Ranks or Mann-Whitney Rank Sum Test) to establish if data were significant. The Holm-Sidak method (ANOVA) or Dunn's method (Ranks) was used for multiple comparisons versus a control group. Results with values of P < 0.05 were considered statistically significant. SigmaPlot 11.0 software was used to perform all statistical analysis. The results presented from the western blots are from four independent experiments for all the antibodies except for p-LIMK1/2, where three independent experiments were used to present the data. Scale bar = 100 μm. Ã P < 0.05. Error bars indicate standard error of mean. Immunohistochemistry data was analysed by oneway ANOVAs and Holm-Sidak's multiple comparison procedures for post-hoc testing. For western blot analysis a Student's t-test was performed. (TIF)
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